IQVIA Holdings Inc. (IQV)
USD 146.15
(2.05%)
USD 146.15
(2.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.23 Billion USD | -17.76% |
| 2022 | 5.02 Billion USD | 8.34% |
| 2021 | 4.64 Billion USD | 20.26% |
| 2020 | 3.85 Billion USD | 1.87% |
| 2019 | 3.78 Billion USD | 3.33% |
| 2018 | 3.66 Billion USD | 6.63% |
| 2017 | 3.43 Billion USD | 61.56% |
| 2016 | 2.12 Billion USD | 32.93% |
| 2015 | 1.6 Billion USD | 8.04% |
| 2014 | 1.48 Billion USD | 10.83% |
| 2013 | 1.33 Billion USD | 8.43% |
| 2012 | 1.23 Billion USD | 7.97% |
| 2011 | 1.14 Billion USD | 2.04% |
| 2010 | 1.11 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.03 Billion USD | -7.44% |
| 2024 Q2 | 1.05 Billion USD | 2.42% |
| 2024 Q3 | 1.37 Billion USD | 30.37% |
| 2023 Q4 | 1.11 Billion USD | -14.89% |
| 2023 Q3 | 1.31 Billion USD | 1.95% |
| 2023 FY | 4.13 Billion USD | -17.76% |
| 2023 Q1 | 1.25 Billion USD | -5.86% |
| 2023 Q2 | 1.28 Billion USD | 2.47% |
| 2022 Q4 | 1.33 Billion USD | 7.33% |
| 2022 Q3 | 1.24 Billion USD | 2.56% |
| 2022 Q2 | 1.21 Billion USD | -2.81% |
| 2022 FY | 5.02 Billion USD | 8.34% |
| 2022 Q1 | 1.24 Billion USD | -2.12% |
| 2021 Q1 | 1.11 Billion USD | -0.89% |
| 2021 Q2 | 1.11 Billion USD | -0.09% |
| 2021 Q3 | 1.13 Billion USD | 2.06% |
| 2021 Q4 | 1.27 Billion USD | 11.78% |
| 2021 FY | 4.64 Billion USD | 20.26% |
| 2020 Q4 | 1.12 Billion USD | 14.2% |
| 2020 Q3 | 986 Million USD | 20.69% |
| 2020 Q2 | 817 Million USD | -12.15% |
| 2020 Q1 | 930 Million USD | -6.44% |
| 2020 FY | 3.85 Billion USD | 1.87% |
| 2019 Q2 | 941 Million USD | 0.53% |
| 2019 FY | 3.78 Billion USD | 3.33% |
| 2019 Q4 | 994 Million USD | 8.4% |
| 2019 Q3 | 917 Million USD | -2.55% |
| 2019 Q1 | 936 Million USD | -1.06% |
| 2018 Q4 | 946 Million USD | 3.28% |
| 2018 Q2 | 893 Million USD | -1.98% |
| 2018 FY | 3.66 Billion USD | 6.63% |
| 2018 Q1 | 911 Million USD | -6.08% |
| 2018 Q3 | 916 Million USD | 2.58% |
| 2017 Q2 | 815 Million USD | 2.0% |
| 2017 Q4 | 970 Million USD | 13.58% |
| 2017 Q1 | 799 Million USD | -5.11% |
| 2017 Q3 | 854 Million USD | 4.79% |
| 2017 FY | 3.43 Billion USD | 61.56% |
| 2016 FY | 2.12 Billion USD | 32.93% |
| 2016 Q3 | 432.63 Million USD | 1.46% |
| 2016 Q2 | 426.42 Million USD | 4.66% |
| 2016 Q1 | 407.45 Million USD | -5.63% |
| 2016 Q4 | 842 Million USD | 94.62% |
| 2015 Q1 | 368.14 Million USD | -5.42% |
| 2015 Q4 | 431.74 Million USD | 5.19% |
| 2015 Q3 | 410.42 Million USD | 5.1% |
| 2015 Q2 | 390.52 Million USD | 6.08% |
| 2015 FY | 1.6 Billion USD | 8.04% |
| 2014 Q3 | 369.96 Million USD | 2.49% |
| 2014 Q2 | 360.96 Million USD | -0.17% |
| 2014 Q1 | 361.56 Million USD | -0.12% |
| 2014 FY | 1.48 Billion USD | 10.83% |
| 2014 Q4 | 389.22 Million USD | 5.21% |
| 2013 Q4 | 361.98 Million USD | 9.02% |
| 2013 Q1 | 316.32 Million USD | -0.3% |
| 2013 FY | 1.33 Billion USD | 8.43% |
| 2013 Q2 | 326.57 Million USD | 3.24% |
| 2013 Q3 | 332.03 Million USD | 1.67% |
| 2012 FY | 1.23 Billion USD | 7.97% |
| 2012 Q1 | 297.47 Million USD | 0.0% |
| 2012 Q4 | 317.28 Million USD | 5.24% |
| 2012 Q2 | 316.69 Million USD | 6.46% |
| 2012 Q3 | 301.48 Million USD | -4.8% |
| 2011 FY | 1.14 Billion USD | 2.04% |
| 2010 FY | 1.11 Billion USD | 0.0% |
| 2001 Q3 | 1.24 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agilent Technologies, Inc. | 3.46 Billion USD | -51.198% |
| Charles River Laboratories International, Inc. | 1.5 Billion USD | -248.673% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -76.933% |
| Danaher Corporation | 14.03 Billion USD | 62.669% |
| Enzo Biochem, Inc. | 14.63 Million USD | -35705.085% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -55.696% |
| Mettler-Toledo International Inc. | 2.24 Billion USD | -133.75% |
| Qiagen N.V. | 1.22 Billion USD | -328.399% |
| Revvity, Inc. | 1.17 Billion USD | -346.033% |
| Thermo Fisher Scientific Inc. | 15.22 Billion USD | 65.587% |
| Waters Corporation | 1.76 Billion USD | -197.469% |